Life sciences firms' likelihood of locating manufacturing facilities in the U.S. 2018
This statistic depicts the percentage of medtech and biopharma firms that are likely to move existing manufacturing facilities or develop new manufacturing facilities in the U.S. due to the tax reform, according to a survey conducted during summer 2018. According to the survey, 48 percent of companies are likely to build new manufacturing facilities in the U.S. at that time.